The promise of integrating omics-driven liquid biopsy and machine learning algorithms with multi-tracer PET in the management of neuroendocrine tumors: envisioning a panoptic model for precision oncology and molecular theranostics
本文未提供摘要，请点击“查看全文”查看完整内容。